![Peizhi Luo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peizhi Luo
Directeur Général chez
ADAGENE INC.
Fortune : 38 M $ au 30/06/2026
Profil
Pei Zhi Luo is the Chairman & Chief Executive Officer of Adagene, Inc., a company he founded in 2011.
He is also the President, Director & Chief Technology Officer of Abmaxis, Inc., a company he founded in 2000.
Dr. Luo previously worked as a Director-Biologics Technology at Merck & Co., Inc. and as a Scientist at Xencor, Inc. He received his undergraduate degree from Peking University in 1986, his doctorate degree from The University of Chicago in 1995, and his graduate degree from the Chinese Academy of Sciences in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADAGENE, INC. 21,04 % | 05/06/2026 | 11 447 474 ( 21,04 % ) | 38 M $ | 30/06/2026 |
Postes actifs de Peizhi Luo
| Sociétés | Poste | Début |
|---|---|---|
| ADAGENE INC. | Directeur Général | 01/11/2011 |
Anciens postes connus de Peizhi Luo
| Sociétés | Poste | Fin |
|---|---|---|
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Fondateur | 06/11/2008 |
| XENCOR, INC. | Corporate Officer/Principal | 01/08/2000 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Formation de Peizhi Luo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
 Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Choisissez Zonebourse 
